BEARINGPOINT
17.9.2020 08:57:22 CEST | Business Wire | Press release
Management and technology consultancy BearingPoint announced today that it has acquired Paris-based Steerio, an engagement platform (SaaS) that leverages smart analytics to push teamwork, feedback and decision-making into the digital age. With the acquisition, BearingPoint expands its portfolio of team and project management assets and enhances its People & Strategy offering that focuses on the people dimension of a company’s strategy.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200916005793/en/
The acquisition is part of a bigger strategic move: the independent consulting firm has been investing for years in new and better ways of working. This includes innovative project and team management and collaboration solutions across business units, countries and teams for more innovation, agile-working, and remote and mobile working - an approach embedded in the firm’s Strategy 2025, which puts people in the center. To accelerate this ambition, BearingPoint also created and included data-driven digital assets and managed services in its portfolio.
Steerio joins BearingPoint’s portfolio of team and project management assets such as Active Manager and enhances its People & Strategy offering. BearingPoint said Steerio will be rolled out to all projects of a certain size and complexity and will form a substantial pillar of the way the firm delivers consulting projects.
“The new normal demands that we create and bring to life new ways of working and related offerings,” said Kiumars Hamidian, Managing Partner BearingPoint. “Putting people in the center is a major ambition driving our Strategy 2025, and the acquisition of Steerio fits well with our portfolio of offerings because Steerio is both people-centric and data-driven at the same time. The Steerio platform opens even more innovative ways to collaborate across teams and firms for the best possible outcomes for our clients.”
“Working and collaboration in the 'new normal' is more important than ever, and Steerio’s smart analytics create an augmented project experience for all our team members, which we especially need in these times of remote working,” adds Damien Palacci, Global Leader Consulting Portfolio at BearingPoint. “It is another tool for us to use and leverage for better teamwork, knowledge transfer, and more innovation. And it also empowers employees and helps them take ownership and be entrepreneurs.”
Steerio captures weak signals and uses “soft-data” analytics and best-practices and team feedback to identify roadblocks and adopt best-practices proactively to secure team effectiveness. It reduces project failure and delays and promotes transparency and trust. Every stakeholder has access to anonymized and objective team results.
“Becoming part of BearingPoint is a giant leap for us, as it significantly increases our ability to provide a wider array of services to our clients,” said Damien Guery, Co-Founder of Steerio. “We can now combine our expertise and assets and leverage them with BearingPoint's extensive industry network. We are going to be able to push teamwork and decision-making into the digital age.”
About Steerio
Paris-based Steerio was started to bring teamwork, feedback and decision-making to the digital age, combining years of practical experience, best-practice methodologies and knowledge in artificial intelligence. By leveraging new types of data and enabling decision makers to access the relevant insights at the right time, Steerio unlocks tremendous efficiency gains in team delivery and improves the collaboration experience while reducing the gap between strategy design and execution.
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: The first unit covers the advisory business with a clear focus on five key areas to drive growth across all regions. The second unit provides IP-driven managed services beyond SaaS and offers business critical services to its clients supporting their business success. The third unit provides the software for successful digital transformation and regulatory requirements. It is also designed to explore innovative business models with clients and partners by driving the financing and development of start-ups and leveraging ecosystems.
BearingPoint's clients include many of the world's leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
View source version on businesswire.com: https://www.businesswire.com/news/home/20200916005793/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Rigaku and Tohoku University Establish a New Research Institute for X-Ray Metrology28.8.2026 16:00:00 CEST | Press release
Rigaku Corporation, a group company of Rigaku Holdings and a global solutions partner for X-ray analytical systems (Head Office: Akishima, Tokyo; President and CEO: Jun Kawakami; “Rigaku”), and Tohoku University (Sendai, Miyagi; President: Teiji Tominaga; “Tohoku University”) have established the Rigaku-Tohoku University Co-Creation Research Institute for X-ray Metrology: Beyond The Limits (the “Institute”) at Tohoku University on August 1, 2026. The Institute will advance X-ray metrology technology, develop new metrology methods, and foster the next generation of researchers through an initial three-year collaboration, with the possibility of extension based on its achievements. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828688510/en/ Inside the Institute As semiconductors become smaller, more multilayered, and incorporate a wider range of materials, manufacturing processes are becoming increasingly complex. X-ray me
BLK: Portfolio Company of Enry’s Island S.p.A., Lists on Euronext Dublin28.8.2026 15:34:00 CEST | Press release
Enry’s Island S.p.A. (WBAG:EIOS), an international venture builder with headquarters in the Tremiti Islands and the Metaverse, announces that BLK Global PLC, one of the portfolio companies within its ecosystem, has successfully completed its admission to trading on Euronext Access Dublin. Trading in the company’s shares commenced on Friday, July 31, 2026, under ticker BLKX and ISIN GB00BPSKS130. BLK was one of the thousands of applications received by Enry’s Island which, following an assessment process based on the Enry’s Model, was selected for a one-year incubation and acceleration programme. The programme supported the company through its subsequent growth stages, ultimately leading to its current stock market listing. Alessandro Pacciana, Investor Relations Manager of Enry’s Island S.p.A., said: “BLK’s listing is the second stock market listing in two years among Enry’s Island’s portfolio companies, while Enry’s Island itself is the world’s first listed venture builder. We are pro
Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release
Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely
MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release
The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav
New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release
Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
